<font color="red">Epidemiology_1</font> <font color="red">of_1</font> <font color="red">stroke_2</font> <font color="red">._2</font> Importance of <font color="red">preventive_1</font> <font color="red">pharmacological_1</font> <font color="red">strategies_1</font> <font color="red">in_1</font> <font color="red">elderly_3</font> <font color="red">patients_3</font> <font color="red">and_1</font> <font color="red">associated_1</font> <font color="red">costs_1</font> <font color="red">._1</font> 
<br>
<br> <font color="red">Stroke_1</font> <font color="red">is_1</font> <font color="red">a_1</font> <font color="red">major_1</font> <font color="red">cause_1</font> <font color="red">of_1</font> <font color="red">death_1</font> <font color="red">and_1</font> <font color="red">disability_1</font> <font color="red">in_1</font> <font color="red">developed_1</font> <font color="red">countries_1</font> <font color="red">._1</font> The incidence of stroke increases exponentially with age , yet , traditionally , many medical practitioners have been reluctant to treat <font color="red">hypertension_4</font> <font color="red">in_4</font> <font color="red">older_4</font> <font color="red">patients_4</font> <font color="red">._4</font> <font color="red">Since_2</font> <font color="red">1991_2</font> <font color="red">,_2</font> <font color="red">the_2</font> <font color="red">results_2</font> <font color="red">of_2</font> <font color="red">3_2</font> <font color="red">major_2</font> <font color="red">trials_2</font> <font color="red">--_2</font> <font color="red">the_2</font> <font color="red">British_3</font> <font color="red">Medical_3</font> <font color="red">Research_3</font> <font color="red">Council_3</font> <font color="red">(_3</font> <font color="red">MRC_3</font> <font color="red">)_3</font> <font color="red">trial_3</font> <font color="red">of_3</font> <font color="red">treatment_4</font> <font color="red">in_4</font> <font color="red">older_4</font> <font color="red">adults_4</font> <font color="red">,_4</font> <font color="red">the_3</font> <font color="red">Swedish_3</font> <font color="red">Trial_3</font> <font color="red">in_3</font> <font color="red">Old_3</font> <font color="red">Patients_3</font> <font color="red">with_3</font> <font color="red">Hypertension_3</font> <font color="red">(_3</font> <font color="red">STOP_3</font> <font color="red">-_3</font> <font color="red">Hypertension_3</font> <font color="red">)_3</font> <font color="red">and_3</font> <font color="red">the_3</font> <font color="red">Systolic_3</font> <font color="red">Hypertension_3</font> <font color="red">in_3</font> <font color="red">the_3</font> <font color="red">Elderly_3</font> <font color="red">Program_3</font> <font color="red">(_3</font> <font color="red">SHEP)--have_3</font> <font color="red">conclusively_3</font> <font color="red">established_3</font> <font color="red">the_3</font> <font color="red">benefits_3</font> <font color="red">of_3</font> <font color="red">treating_4</font> <font color="red">older_5</font> <font color="red">patients_5</font> <font color="red">(_5</font> <font color="red">>_5</font> <font color="red">60_5</font> <font color="red">years_5</font> <font color="red">)_5</font> <font color="red">with_4</font> <font color="red">both_4</font> <font color="red">diastolic_4</font> <font color="red">and_4</font> <font color="red">isolated_4</font> <font color="red">systolic_4</font> <font color="red">hypertension_4</font> <font color="red">._4</font> International guidelines for the management of hypertension -- including the Fifth Report of the Joint National Committee , the 1993 report of the World Health Organization and the International Society of Hypertension and the second report of the British Hypertension Society Working Party -- have all been modified to reflect the emerging evidence concerning the benefits of treating older patients . Cost - effectiveness data are similarly in accord with giving high priority to <font color="red">the_1</font> <font color="red">treatment_2</font> <font color="red">of_2</font> <font color="red">older_3</font> <font color="red">individuals_3</font> <font color="red">with_3</font> <font color="red">hypertension_3</font> <font color="red">._3</font>